Polypill Effects on Sub Clinical Atherosclerosis (PESCA) Trial
Summary
Medications that lower blood pressure and cholesterol are known to improve the shape and function of our blood vessels. These improvements include a reduction in the thickness of the wall of the carotid artery (the main artery that runs up the neck to supply the brain) and a reduction in the stiffness of arteries generally including the main central artery -the aorta. Such medications are in the polypill (the Red Heart Pill) that is being used in the UMPIRE Study. In UMPIRE, patients' reported adherence to taking the single, once daily polypill is being compared to adherence to medications taken as separate tablets (usual care).The aim of the PESCA sub-study is to see whether or not the polypill differs from 'usual care' in its direct effects on blood vessels as shown by ultrasound examination of the carotid arteries and assessment of central (aortic) blood pressure.
Timeline
- Start
- 2011-02
- Primary completion
- 2012-07
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 75 mg | Oral |
| Subject | Atenolol | Other / unclassified | 50 mg | Oral |
| Subject | Hydrochlorothiazide | Unknown | 12.5 mg | Oral |
| Subject | LISINOPRIL ANHYDROUS | Small molecule | 10 mg | Oral |
| Subject | Simvastatin | Small molecule | 40 mg | Oral |